12 - 14 November, 2019 | London, UK

Lior Raviv

Vice President Of Development
Pluristem Therapeutics

9:10 AM It May Sound Crazy But… Addressing Scalability at the Beginning NOT the End

  • Conduct a cost-benefit analysis of the differences between proactive automation for scale and reactive scalability
  • Create a manufacturing process that is flexible enough to deliver lean production across pre-clinical and clinical development
  • Adopt best-in-class technology to assist in in-house manufacturing rather than outsourcing your production

Check out the incredible speaker line-up to see who will be joining Lior.

Download The Latest Agenda